|
It was reported that the patient underwent surgery to implant a tfna in (b)(6) 2022.The nail was removed on (b)(6) 2023 due to a periprosthetic fracture occurring distal to the short tfna.The fracture was noticed along the shaft of the nail.The surgeon suspects that the fracture was there before the nail was placed.During the procedure, the rubber tips on the reaming rod were hard to remove, however they were removed and the surgery was completed successfully.This report involves one tfna fenestrated screw 80mm.This is report 3 of 4 for (b)(4).
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Additional narrative: additional device product codes: hsb.Implantation date was an unknown day in (b)(6) 2022.Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|